A team of mathematical experts have said that 1729, which is also known as the Ramanujan-Hardy number, is linked to aspects of string theory and...
Researchers and healthcare experts are hopeful on a mix of drugs to effectively treat aaggressive form of breast cancer that is resistant to standard treatments.
The researchers are testing a new type of drug, copanlisib that is being tried on women with HER2-positive breast cancer that tends to spread more quickly than other forms on the disease. The research, which is funded by Irish Cancer Society, will use copanlisibto effectively treat women with the type of cancer.
Researcher Naomi Elstersaid that the drugs acts as a "signal blocker" in cancer cells when combined with regular therapies and it may help stop the spread of the disease. A total of 30 women are involved in trial and around 200 patients could potentially benefit from the breakthrough at any one time.
Ms Elster said, “The research, for the first time, shows this combination of drugs offers greater hope of halting the growth and spread of breast cancer cells, compared to each of the drugs alone.The combination of drugs has also proven to be effective in breast cancer cells which have become resistant to certain treatments. The fact this drug is now going to clinical trial has the potential to really make a difference where needed and is aimed at patients who have fewer treatment options than others.”